Recently in Research and Development Category

Sydney, Sep 27, 2007 (RWE via COMTEX) -- STCSF | charts | news | PowerRating -- A BIOTECH AT AN EXCITING STAGE OF ITS DEVELOPMENT TECHNOLOGY (RWE Aust Business News) OVERVIEW

Stem Cell Sciences plc (ASX:STC) is at an exciting stage of its research into technology which could unlock the key to treat cancer, Alzheimer's, stroke and epilepsy.
 
Ferret's Stock to Watch: STEM CELL SCIENCES PLC
 (tradingmarkets.com)

Cloning. Stem cells. Regenerative medicine. These are terms you may have heard or read about in the news over the last decade.

For students in Stem Cells and Cloning taught by Visiting Professor of Biology Bill Anderson, these are topics they will be examining first hand â€" literally. They will perform experiments most undergraduates just read about. Some of the laboratory exercises include splitting flatworms to observe re-growth of entire body parts and instructing mouse embryonic stem (ES) cells to develop into specialized tissue.

Stem cell lab pushes conventional boundaries
 (phoenix.swarthmore.edu)

Stempro hESC SFM is the first serum- and feeder-free media for hESCs that has been shown to maintain these cells in a genetically normal state
Invitrogen has launched a new fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells (hESCs).

Human embryonic stem cell media 'breakthrough'
 (laboratorytalk.com)

University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and Rutgers University have come together to propose a new organization called the Stem Cell Institute of New Jersey. If funding passes for the institute, this statewide initiative would build a research building dedicated to the study of stem cells, with over 400 million dollars from the state to do so.
 
UMDNJ conceives stem cell institute
 (media.www.dailytargum.com)

Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease - a fatal disorder for which there is currently no cure or even a treatment to slow the disease.
In a paper published Sept. 20 in the Journal of Clinical Investigation, scientists at the University of Rochester Medical Center have shown how stem-cell therapy might someday be used to treat the disease. The team used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington's. The mice that were treated lived significantly longer, were healthier, and had many more new, viable brain cells than their counterparts that did not receive the treatment.
 
Stem-cell therapy opens new avenue of research against Huntington's disease
 (news-medical.net)

Lung cells made from embryonic stem cells have been injected into live animals for the first time. All the mouse cells settled in the lungs, raising hopes that the human equivalent could find and repair damage in people with lung disease.
 
Stem cells may breathe new life into lung therapy
 (newscientist.com)

 The NIH unveiled its new plan last week for funding research on alternative sources of embryonic stem cellsâ€"essentially embryonic stem cells that aren’t derived from embryos. This plan comes under the aegis of the president’s Executive Order 13435, which requires the Department of Health and Human Services to “conduct and support research on the isolation, derivation, production, and testing of stem cells that are capable of producing all or almost all of the cell types of the developing body ... but are derived without creating a human embryo ... or subjecting to harm a human embryo or fetus.”
 
Jumping the Gun on Alternative Sources of Stem Cells
 (americanprogress.org)

For more than a decade, Steve Stice has dedicated his research using embryonic stem cells to improving the lives of people with degenerative diseases and debilitating injuries. His most recent discovery, which produces billions of neural cells from a few stem cells, could now aid in national security.

“It's like a canary-in-a-coal-mine scenario,” said Stice, a University of Georgia animal science professor and Georgia Research Alliance eminent scholar in the UGA College of Agricultural and Environmental Sciences.

New Use For Stem Cells Found In War On Terrorism
(sciencedaily.com)

Sydney, Sep 26, 2007 (RWE via COMTEX) -- STCSF | charts | news | PowerRating -- (RWE Aust Business News) Stem Cell Sciences plc (ASX:STC) will lead an EU-funded, multinational novel drug screening collaboration using stem cells.

The project, named NEUROscreen, will use Stem Cell Sciences' proprietary neural stem (NS) cell technology and has received a contribution from the EU's 6th Framework Program for Research and Technical Development (FP6).

The EU's contribution to the NEUROscreen project is worth 2.4 million euro over three years, of which approximately 420,000 euro will flow directly to SCS over the three year period.
 
Stem Cell Sciences to lead EU-funded drug discovery
(tradingmarkets.com)

Scientists have discovered a new way of treating liver failure that could save the lives of thousands of patients on transplant waiting lists.

The technique involves inserting stem cells into the damaged organ so that it is encouraged to repair itself and create new tissue.

According to the researchers, the treatment will allow patients to live long enough for a new organ to found and could even enable the liver to completely heal itself so a transplant is no longer needed.
 
Stem cell therapy 'could cut liver transplants'
(telegraph.co.uk)